Skip to main content
Caplight Logo









RevealDx

RevealDx

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://reveal-dx.com

Last Round

Strategic

Aug 3, 2026

Est. Valuation

$34M

Total Funding Raised

$9.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RevealDx is a healthcare AI company that provides RevealAI-Lung, a software for the characterization of lung nodules from CT scans to improve diagnostic precision.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

clinical decision supportlung nodule analysisAI radiologymedical imaging AIlung cancer screeningradiology AIradiomicsdiagnostic softwareAI diagnosticsPACS integrationmedical softwareSaaShealthtechmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RevealDx Comparables

Compare RevealDx with similar companies based on industry and business-model similarity.

RevealDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Optellum
92%
contextflow
85%
Coreline Soft
80%

RevealDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicAug 3, 2026
Series AJul 23, 2024
M&AMar 23, 2021
SeedDec 1, 2016

RevealDx Investors

Notable investors and investment history

RevealDx investors
InvestorRounds
A-Level CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    $3.4M round led by 4DMedical Limited

  • Nov 3, 2025

    MDR Certification granted for RevealAI-Lung product.

Recent news

Latest coverage and updates

  • receives_financingAug 10, 2026

    Reveal Dx received financing of $3.4M in investment on Jul 8th '26.

RevealDx Filings

Explore SEC and related filing metadata, where available.

RevealDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RevealDx's valuation, stock price, and market status.

Is RevealDx a public or private company?

RevealDx is a private company.

What is the current stock price of RevealDx?

RevealDx is a private company, so its shares have no public market price. Caplight tracks RevealDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RevealDx worth (valuation)?

RevealDx's valuation is estimated at $34.0M based on funding round data.

Can I buy RevealDx stock?

RevealDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RevealDx's last funding round?

RevealDx's most recent funding round was Strategic on August 3, 2026.

Who are the main investors in RevealDx?

Key investors in RevealDx include A-Level Capital.

Will RevealDx IPO soon?

No public IPO plans have been announced for RevealDx.

How can I track RevealDx secondary market activity?

Caplight tracks bids, offers, and trades in RevealDx's shares on secondary markets.

Firmographic Details

HeadquartersSeattle, Washington
Year Founded2021
Last FundingAug 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?